Neogen (NEOG) Up 6.7% Since Last Earnings Report: Can It Continue?
Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research11/5/2026Positive
NEOG
Neogen CorporationNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$2.57B
P/E Ratio
—
EPS
$-0.26
Beta
1.86
52W High
$14.26
52W Low
$5.37
50-Day MA
$12.25
200-Day MA
$10.48
Dividend Yield
—
Profit Margin
-6.35%
Forward P/E
16.00
PEG Ratio
0.66
About Neogen Corporation
Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.
Fundamentals
| Revenue (TTM) | $884.00M |
| Gross Profit (TTM) | $419.00M |
| EBITDA | $109.00M |
| Operating Margin | -0.81% |
| Return on Equity | -2.67% |
| Return on Assets | -0.14% |
| Revenue/Share (TTM) | $4.06 |
| Book Value | $9.56 |
| Price-to-Book | 1.22 |
| Price-to-Sales (TTM) | 2.90 |
| EV/Revenue | 3.566 |
| EV/EBITDA | 28.65 |
| Quarterly Earnings Growth (YoY) | -85.60% |
| Quarterly Revenue Growth (YoY) | 6.50% |
| Shares Outstanding | $218.31M |
| Float | $217.24M |
| % Insiders | 0.79% |
| % Institutions | 111.16% |
Historical Volatility
HV 10-Day
48.00%
HV 20-Day
40.94%
HV 30-Day
52.72%
HV 60-Day
43.98%
HV Rank
62.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.00 target)
2
Strong Buy1
Buy1
HoldLatest News
Neogen® To Participate in 2026 UBS Global Healthcare Conference
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2026 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Tuesday, November 10. About Neogen Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock,.
Business Wire11/3/2026Neutral
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
PRNewsWire10/29/2026Neutral
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
PRNewsWire10/22/2026Neutral
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
GlobeNewsWire10/20/2026Neutral
NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?
Neogen beats Where Food Comes From in revenue growth and recovery potential, but higher debt and integration risks complicate the food safety stock showdown.
Zacks Investment Research10/20/2026Positive
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) investors concerning the Company's possible violations of the federal securities laws.
GlobeNewsWire10/15/2026Neutral
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
PRNewsWire10/15/2026Neutral
Neogen Corporation (NEOG) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa. , Oct. 15, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.
GlobeNewsWire10/15/2026Neutral
3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
Zacks Investment Research10/9/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NEOG and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 11/7/2026